Advertisement
Research Article| Volume 2, ISSUE 1, P87-106, March 1982

Download started.

Ok

Therapeutic Hemapheresis

  • Jacob Nusbacher
    Correspondence
    Corresponding author: American Red Cross Blood Services, Rochester Region, 50 Prince Street, Rochester, New York 14607
    Affiliations
    Director, American Red Cross Blood Services, Rochester Region; Professor of Medicine and Pathology, University of Rochester School of Medicine, Rochester, New York
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)31055-2
Therapeutic Hemapheresis
Previous ArticleBlood Transfusion in Heart Surgery
Next ArticleDiagnosis, Prevention, and Therapy in Hemolytic Disease of the Newborn
      This paper is only available as a PDF. To read, Please Download here.
      Therapeutic hemapheresis rarely is directed at the underlying abnormality of the blood or plasma constituent, but rather at secondary manifestations. It is most appropriate when an acute effect is desired, as a substitute when conventional therapy fails or is contraindicated, or as an adjunctive measure to other treatment when it is desirable to accelerate recovery. Conditions that may benefit from plasma exchange, leukapheresis, plateletpheresis, and stem cell collection are discussed.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Abboud C.N.
        • Brennan J.K.
        • Lichtman M.A.
        • et al.
        Quantification of erythroid and granulocytic precursor cells in plateletpheresis residues.
        Transfusion. 1980; 20: 9
        • Abramson N.
        • Eisenberg P.D.
        • Aster R.H.
        Post-transfusion purpura: Immunologic aspects and therapy.
        N. Engl. J. Med. 1974; 291: 1163
        • Amorosi E.L.
        • Ultmann J.E.
        Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature.
        Medicine. 1966; 45: 139
        • Bensinger W.I.
        • Baker D.A.
        • Buckner C.D.
        • et al.
        Immunoadsorption for removal of A and B blood group antibodies.
        N. Engl. J. Med. 1981; 304: 160
        • Bensinger W.I.
        • Baker D.A.
        • Buckner C.D.
        • et al.
        In vitro and in vivo removal of anti-A erythrocyte antibody by adsorption to a synthetic immunoadsorbant.
        Transfusion. 1981; 21: 335
        • Berkman E.M.
        • Caplan S.
        • Kim G.S.
        ABO-incompatible bone marrow transplantation: Preparation by plasma exchange and in vivo antibody absorption.
        Transfusion. 1978; 18: 504
        • Berkman E.M.
        • Orlin J.B.
        Use of plasmapheresis and partial plasma exchange in the management of patients with cryoglobulinemia.
        Transfusion. 1980; 20: 171
        • Bongiovanni M.B.
        • Katz R.S.
        • Tomaszewski J.E.
        • et al.
        Cytapheresis in a patient with Sezary syndrome.
        Transfusion. 1981; 21: 332
        • Branda R.F.
        • Modlow G.F.
        • McCullough J.J.
        • et al.
        Plasma exchange in the treatment of immune disease.
        Transfusion. 1975; 15: 570
        • Branda R.F.
        • Tate D.Y.
        • McCullough J.J.
        • et al.
        Plasma exchange in the treatment of fulminant idiopathic (autoimmune) thrombocytopenic purpura.
        Lancet. 1978; 1: 688
        • Brody J.I.
        • Goldsmith M.H.
        • Park S.K.
        • et al.
        Symptomatic crisis of sickle cell anemia treated by limited exchange transfusion.
        Ann. Intern. Med. 1970; 72: 327
        • Buckner C.D.
        • et al.
        ABO-incompatible marrow transplants.
        Transfusion. 1978; 26: 233
        • Bukowski R.M.
        • King J.W.
        • Hewlett J.S.
        Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura.
        Blood. 1977; 50: 413
        • Buskard N.A.
        • et al.
        Plasma exchange in the long-term management of Waldenstrom’s macroglobulinemia.
        Can. Med. Assoc. J. 1977; 117: 135
        • Byrnes J.J.
        • Khurana M.
        Treatment of thrombotic thrombocytopenic purpura with plasma.
        N. Engl. J. Med. 1977; 297: 1386
        • Byrnes J.J.
        • Lian E.C.Y.
        Recent therapeutic advances in thrombotic thrombocytopenic purpura.
        Semin. Thromb. Hemostas. 1979; 5: 199
        • Caplan S.M.
        • Coco F.V.
        • Berkman E.M.
        Management of chronic myelocytic leukemia in pregnancy by cell pheresis.
        Transfusion. 1978; 18: 120
        • Cimo P.I.
        • Aster R.H.
        Post-transfusion purpura. Successful treatment by exchange transfusion.
        N. Engl. J. Med. 1972; 287: 290
        • Collins J.A.
        Problems associated with the massive transfusion of stored blood.
        Surgery. 1974; 75: 274
        • Corash L.
        • et al.
        Selective isolation of young erythrocytes for transfusion support of thalassemia major patients.
        Blood. 1981; 57: 599
        • Cundall J.R.
        • Moore W.H.
        • Jenkins D.E.
        Erythrocyte exchange in paroxysmalnocturnal hemoglobinuria prior to cardiac surgery.
        Transfusion. 1978; 18 (abstract): 626
        • Curtis J.E.
        • Hersh E.M.
        • Freireich E.J.
        Leukapheresis therapy of chronic lymphocytic leukemia.
        Blood. 1972; 39: 163
        • Cuttner J.
        Thrombotic thrombocytopenic purpura: A ten-year experience.
        Blood. 1980; 56: 302
        • Dau P.C.
        • Lindstrom J.M.
        • Cassel C.K.
        • et al.
        Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
        New Engl. J. Med. 1977; 297: 1134
        • Dau P.C.
        • Lindstrom J.M.
        • Cassel C.K.
        • et al.
        Plasmapheresis in myasthenia gravis and polymyositis.
        in: Dau P.C. Plasmapheresis and the Immunobiology of Myasthenia Gravis. Houghton Mifflin, Boston1979: 229
        • Edelson R.
        • Facktor M.
        • Andrews A.
        • et al.
        Successful management of the Sezary syndrome.
        N. Engl. J. Med. 1974; 291: 293
        • Eisenstadt R.S.
        • Berkman E.M.
        Rapid cytoreduction in acute leukemia. Management of cerebral leukostasis by cell pheresis.
        Transfusion. 1978; 15: 113
        • Fay J.W.
        • Moore J.O.
        • Logue G.L.
        • et al.
        Leukopheresis therapy of leukemic reticuloen-dotheliosis (hairy cell leukemia).
        Blood. 1979; 54: 747
        • Flaum M.A.
        • Cuneo R.A.
        • Applebaum F.R.
        • et al.
        The hemostatic imbalance of plasma-exchange transfusion.
        Blood. 1979; 54: 694
        • Fraser I.D.
        • et al.
        Intensive antenatal plasmapheresis in severe rhesus immunization.
        Lancet. 1976; 1: 6
        • Freireich E.J.
        • Judson G.
        • Levin R.H.
        Separation and collection of leukocytes.
        Cancer Res. 1965; 24: 1516
        • Fritz R.D.
        • Forkner G.E.
        • Freireich E.J.
        • et al.
        The association of fatal intracranial hemorrhage and “blastic crisis” in patients with acute leukemia.
        N. Engl. J. Med. 1959; 261: 59
        • Gibberg F.B.
        • Billimoria J.D.
        • Page N.G.R.
        • et al.
        Heredopathia atactica polyneuritiformis (Refsum’s disease) treated by diet and plasma exchange.
        Lancet. 1979; 1: 575
        • Goldfinger D.
        • Thompson R.
        • Lowe C.
        • et al.
        Long-term plateletpheresis in the management of primary thrombocytosis.
        Transfusion. 1979; 19: 336
        • Goldman J.M.
        • Catovsky D.
        • Galton D.A.G.
        Reversal of blast-cell crisis in C. G. L. by transfusion of stored autologous buffy-coat cells.
        Lancet. 1978; 1: 437
        • Graham-Pole J.
        • Barr W.
        • Willoughby M.L.N.
        Continuous-flow plasmapheresis in management of severe rhesus disease.
        Br. Med. J. 1977; 1: 1185
        • Greenberg B.R.
        • Watson-Williams E.J.
        Successful control of life-threatening thrombocytosis with a blood processor.
        Transfusion. 1975; 15: 620
        • Harmer D.
        • Finn R.
        • Goldsmith H.J.
        • et al.
        Plasmapheresis in fulminating crescentic nephritis.
        Lancet. 1979; 1: 679
        • Harris A.L.
        Leukostasis associated with blood transfusion in acute myeloid leukaemia.
        Br. Med. J. 1978; 1: 1169
        • Hocker P.
        • Pitterman E.
        • Gobets M.
        • et al.
        Treatment of patients with chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) by leukapheresis with a continuous flow blood cell separator.
        in: Goldman J.M. Lowenthal R.M. Leukocytes: Separation, Collection and Transfusion. Academic Press, London1975: 510-518
        • Huestis D.W.
        • Corrigan J.J.
        • Johnson H.V.
        Leukapheresis of a five-year-old girl with chronic granulocytic leukemia.
        Transfusion. 1975; 15: 489
        • Huestis D.W.
        • Price M.J.
        • White R.F.
        • et al.
        Leukapheresis of patients with chronic granulocytic leukemia (CGL), using the Haemonetics Blood Processor.
        Transfusion. 1976; 16: 255
        • Imbach P.
        • Barandun S.
        • Baumgartner C.
        • et al.
        High-dose intravenous gamma globulin therapy of refractory, in particular idiopathic thrombocytopenia in childhood.
        Helv. Paediatr. Acta. 1981; 46: 81
        • Kernoff L.M.
        • Botha M.B.
        • Jacobs P.
        Exchange transfusions in sickle cell disease using a continous-flow blood separator.
        Transfusion. 1977; 17: 269
        • Lanzowsky P.
        • Shende A.
        • Karayalcin G.
        • et al.
        Partial exchange transfusion in sickle cell anemia.
        Am. J. Dis. Child. 1978; 132: 1206
        • Lawson N.S.
        • Nosanchuk J.S.
        • Oberman H.A.
        • et al.
        Therapeutic plasmapheresis in treatment of patients with Waldenstrom’s macroglobulinemia.
        Transfusion. 1968; 8: 174
        • Lian E.C.Y.
        • Harkness D.R.
        • Byrnes J.J.
        • et al.
        Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma.
        Blood. 1979; 53: 333
        • Lichtman M.A.
        Rheology of leukocytes, leukocyte suspensions, and blood in leukemia.
        J. Clin. Invest. 1973; 52: 350
        • Lindsely H.
        • Teller D.
        • Noonan B.
        • et al.
        Hyperviscosity syndrome in multiple myeloma. A reversible, concentration-dependent aggregation of the myeloma protein.
        Am. J. Med. 1973; 54: 682
        • Lisak R.P.
        • Abramsky O.
        • Schotland D.L.
        Plasmapheresis in the treatment of myasthenia gravis: Preliminary studies in 21 patients.
        in: Dau P.C. Plasmapheresis and the Immunobiology of Myasthenia Gravis. Houghton Mifflin, Boston1979: 209
        • Lockwood C.M.
        • Rees A.J.
        • Pearson T.A.
        • et al.
        Immunosuppression and plasma-exchange in the treatment of Goodpasture’s syndrome.
        Lancet. 1976; 1: 711
        • Lockwood C.M.
        • Rees A.J.
        • Pinching A.J.
        • et al.
        Plasma-exchange and immunosuppression in the treatment of fulminant immune-complex crescentic nephritis.
        Lancet. 1977; 1: 63
        • Logue G.L.
        • Rosse W.F.
        • Gockerman J.P.
        Measurement of the third component of complement bound to red blood cells in patients with cold agglutinin syndrome.
        J. Clin. Invest. 1973; 52: 493
        • Lowenthal R.M.
        • et al.
        Intensive leukapheresis as initial therapy for chronic granulocytic leukemia.
        Blood. 1975; 46: 835
        • Luxemberg M.N.
        • Mausolf F.A.
        Retinal circulation in the hyperviscosity syndrome.
        Am. J. Ophthalmol. 1970; 70: 588
        • MacPherson J.I.
        • Nusbacher J.
        • Bennett J.M.
        The acquisition of granulocytes by leukapheresis: A comparison of continuous flow centrifugation and filtration leukapheresis in normal and corticosteroid-stimulated donors.
        Transfusion. 1976; 16: 221
        • Marder V.J.
        • Nusbacher J.
        • Anderson F.W.
        One-year follow-up of plasma exchange therapy in 14 patients with idiopathic thrombocytopenic purpura.
        Transfusion. 1981; 21: 291
        • Marsaglia G.
        • Thomas E.D.
        Mathematical consideration of cross circulation and exchange transfusion.
        Transfusion. 1971; 11: 216
        • McCullough J.
        • Fortuny I.E.
        • Kennedy B.J.
        • et al.
        Rapid plasma exchange with the continuous-flow centrifuge.
        Transfusion. 1973; 13: 94
        • McKee L.C.
        • Collins R.D.
        Intravascular leukocyte thrombi and aggregates as a cause of morbidity and mortality in leukemia.
        Medicine. 1974; 53: 463
        • McLeod B.C.
        • Sassetti R.J.
        Plasmapheresis with return of cryoglobulin-depleted autologous plasma (cryoglobulinpheresis) in cryoglobulinemia.
        Blood. 1980; 55: 866
        • Misiani R.
        • Bertani T.
        • Licini R.
        • et al.
        Asphyxia in Goodpasture’s syndrome: Early treatment by immunosuppression and plasma exchange.
        Lancet. 1978; 1: 552
        • Morse E.E.
        • Carbone P.P.
        • Freireich E.J.
        • et al.
        Repeated leukapheresis of patients with chronic myelocytic leukemia.
        Transfusion. 1966; 6: 175
        • Myers T.J.
        • Wakem C.J.
        • Ball E.D.
        • et al.
        Thrombotic thrombocytopenic purpura: Combined treatment with plasmapheresis and antiplatelet agents.
        Ann. Intern. Med. 1980; 92: 149
        • Newsome-Davis J.
        • Ward C.D.
        • Wilson S.G.
        • et al.
        Plasmapheresis: Short- and long-term benefits?.
        in: Dau P.C. Plasmapheresis and the Immunobiology of Myasthenia Gravis. Houghton Mifflin, Boston1979: 199
        • Newsome-Davis J.
        • Wilson S.G.
        • Vincent A.
        • et al.
        Long-term effects of repeated plasma exchange in myasthenia gravis.
        Lancet. 1979; 1: 464
        • Nguyen B.T.
        • Perkins H.A.
        Quantitation of granulocyte-macrophage projenitor cells (CFU-C) in plateletpheresis and leukapheresis concentrates.
        Blood Transf. Immunohaematol. 1979; 22: 489
        • Nillson I.M.
        • Jonsson S.
        • Sundqvist S.B.
        • et al.
        A procedure for removing high titer antibodies by extracorporeal protein-A-Sepharose adsorption in hemophilia: Substitution therapy and surgery in a patient with hemophilia B and antibodies.
        Blood. 1981; 58: 38

      69. Nusbacher, J.: Unpublished observations.

        • Nusbacher J.
        • Scher M.L.
        • MacPherson J.L.
        Plateletpheresis using the Haemonetics Model 30 cell separator.
        Vox Sang. 1977; 33: 9
        • Orlin J.B.
        • Berkman E.M.
        Partial plasma exchange using albumin replacement: Removal and recovery of normal plasma constituents.
        Blood. 1980; 56: 1055
        • Panlilio A.L.
        • Reiss R.F.
        Therapeutic plateletpheresis in thrombocythemia.
        Transfusion. 1979; 19: 147
        • Patten E.
        • Reuter F.P.
        • Castle R.
        • et al.
        Evans’ syndrome: Benefit from plasma exchange.
        Transfusion. 1978; 18: 383
        • Penovich P.E.
        • Hollander J.
        • Nusbacher J.
        • et al.
        Note on plasma exchange therapy in Refsum’s disease.
        in: Karp R.A.P. Rosenberg R.N. Schut L.J. Advances in Neurology. Vol. 21. Raven Press, New York1978: 151
        • Petz L.D.
        • Garratty G.
        Acquired Immune Hemolytic Anemias.
        Churchill Livingstone, New York1980: 418-425
        • Pineda A.A.
        • Brzica S.M.
        • Taswell H.F.
        Continuous- and semicontinuous-flow blood centrifugation systems: Therapeutic applications, with plasma-, platelet-, lympha-, and eosinapheresis.
        Transfusion. 1977; 17: 407
        • Pintado T.
        • Taswell H.F.
        • Bowie E.J.W.
        Treatment of life-threatening hemorrhage due to acquired factor VIII inhibitor.
        Blood. 1975; 46: 535
        • Pisciotta A.V.
        • Garthwaite T.
        • Darin J.
        • et al.
        Treatment of thrombotic thrombocytopenic purpura by exchange transfusion.
        Am. J. Hematol. 1977; 3: 73
        • Powles R.
        • Smith C.R.
        • Hamilton Fairley G.
        Method of removing abnormal protein rapidly from patients with malignant paraproteinemias.
        Br. Med. J. 1971; 2: 664
        • Propper R.D.
        Current concepts in the overall management of thalassemia.
        Ann. N.Y. Acad. Sei. 1980; 344: 375
        • Propper R.D.
        • Button L.M.
        • Nathan D.G.
        New approaches to the transfusion management of thalassemia.
        Blood. 1980; 55: 55
        • Ricks P.
        Further experience with exchange transfusion in sickle cell anemia and pregnancy.
        Am. J. Obstet. Gynecol. 1968; 100: 1087
        • Robinson E.A.E.
        • Tovey L.A.D.
        Intensive plasma exchange in the management of severe Rh disease.
        Br. J. Haematol. 1980; 45: 621
        • Rosenfield R.E.
        • Jagathambal
        Transfusion therapy for autoimmune hemolytic anemia.
        Semin. Hematol. 1976; 13: 311
        • Rossi E.C.
        • delGreco F.
        • Kwaan H.C.
        • et al.
        Hemodialysis-exchange transfusion for treatment of thrombotic thrombocytopenic purpura.
        J.A.M.A. 1980; 244: 1466
        • Rubenstein M.A.
        • Kagan E.M.
        • MacGillviray M.H.
        • et al.
        Unusual remission in a case of thrombotic thrombocytopenic purpura syndrome following fresh blood exchange transfusions.
        Ann. Intern. Med. 1959; 51: 1409
        • Russell J.A.
        • Toy J.L.
        • Powles R.L.
        Plasma exchange in malignant paraproteinemias.
        Exp. Hematol. 1977; 5: 105
        • Schulman I.
        • Pierce M.
        • Lukens A.
        • et al.
        Studies in thrombopoiesis. I. A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency.
        Blood. 1960; 16: 943
        • Skoog W.A.
        • Adams W.S.
        • Coburn J.W.
        Metabolic balance study of plasmapheresis in a case of Waldenstrom’s macroglobulinemia.
        Blood. 1962; 19: 425
        • Solomon A.
        • Fahey J.L.
        Plasmapheresis therapy in macroglobulinemia.
        Ann. Intern. Med. 1963; 58: 789
        • Stirling M.L.
        • Parker A.C.
        • Keller A.J.
        • et al.
        Leukapheresis for papilloedema in chronic granulocytic leukaemia.
        Br. Med. J. 1977; 2: 676
        • Taft E.G.
        Thrombotic thrombocytopenic purpura and dose of plasma exchange.
        Blood. 1979; 54: 842
        • Taft E.G.
        • Babcock R.B.
        • Scharfman W.B.
        • et al.
        Plateletpheresis in the management of thrombocytosis.
        Blood. 1977; 50: 927
        • Taft E.G.
        • Propp R.P.
        • Sullivan S.A.
        Plasma exchange for cold agglutinin hemolytic anemia.
        Transfusion. 1977; 17: 173
        • Talpos G.
        • Horrocks M.
        • White J.M.
        • et al.
        Plasmapheresis in Raynaud’s disease.
        Lancet. 1978; 1: 416
        • Thompson G.R.
        • Lowenthal R.
        • Myant N.B.
        Plasma exchange in the management of homozygous familial hypercholesterolaemia.
        Lancet. 1975; 1: 1208
        • Tilz G.P.
        • Weiss P.A.M.
        • Teubl I.
        • et al.
        Successful plasma exchange in rhesus incompatibility.
        Lancet. 1977; 2: 203
        • Vallejos G.S.
        • McCredie K.B.
        • Britten G.M.
        • et al.
        Biological effects of repeated leukapheresis of patients with chronic myelogenous leukemia.
        Blood. 1973; 49: 925
        • Verrier Jones J.
        • Fraser I.D.
        • Bothamley J.
        • et al.
        A therapeutic role for plasmapheresis in the management of acute systemic lupus erythematosus.
        Plasma Ther. 1979; 1: 33
        • Watson D.K.
        • Penny A.F.
        • Marshall R.W.
        • et al.
        Citrate induced hypocalcemia during cell separation.
        Br. J. Haematol. 1980; 44: 503
        • Widmann F.K.
        Technical methods and procedures of the American Association of Blood Banks.
        Edition 8. American Association of Blood Banks, Washington, D. C.1981: 17

      102. Yarrish, R. L., Janas, J. S., Nosanchuk, J. S., et al.: Transfusion-acquired falciparum malaria: Treatment with exchange transfusion following delayed diagnosis. Arch. Intern. Med., in press.

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)31055-2

      Copyright

      © 1982 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX